Senescence in premalignant tumours
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Oncogene-induced senescence is a cellular response that may be crucial for protection against cancer development, but its investigation has so far been restricted to cultured cells that have been manipulated to overexpress an oncogene. Here we analyse tumours initiated by an endogenous oncogene, ras, and show that senescent cells exist in premalignant tumours but not in malignant ones. Senescence is therefore a defining feature of premalignant tumours that could prove valuable in the diagnosis and prognosis of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lastly, in mice and humans, a senescence response to strong mitogenic signals, such as those delivered by certain oncogenes, prevents premalignant lesions from progressing to malignant cancers [ 16 – 19 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [16]
In the citing paper
“In addition to identifying known cell-cycle regulators, these studies identified DCR2 as a common marker of senescence (Collado et al., 2005), later shown to characterize other types of senescence.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Collado et al., 2005
In the citing paper
“OIS or senescence induced by loss of a tumor suppressor was verified in vivo in human and murine preneoplastic lesions (Collado et al., 2005; Gorgoulis and Halazonetis, 2010; Kuilman and Peeper, 2009) and primary or treated neoplasias (Haugstetter et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Collado et al., 2005
In the citing paper
“Studies in various mouse models, supported by correlative evidence from human- derived tissue samples, have underscored the tumour- suppressive role of OIS 81,120-123 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [122]
In the citing paper
“This type of oncogene-induced senescence (OIS) is frequently observed in premalignant and benign tumour tissues [37 -39] but not in advanced malignant tumours, where cancer cells have already bypassed senescence.”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [38]
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
Tuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00085-6 · Cited by 798
p19ARF links the tumour suppressor p53 to Ras
Palmero, I., Pantoja, C., & Serrano, M. (1998) · Nature · doi:10.1038/25870 · Cited by 615
Self-citationTumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M., Campuzano, V., & Barbacid, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00191-0 · Cited by 571
Self-citation
Cited by
Items 801–900 of 1,005
Ras, PI3K/Akt and senescence: Paradoxes provide clues for pancreatic cancer therapy
Kennedy, A. L., Adams, P. D., & Morton, J. P. (2011) · Small GTPases · doi:10.4161/sgtp.2.5.17367 · Cited by 37
XPO7 is a tumor suppressor regulating p21CIP1-dependent senescence
Innes, A. J., Sun, B., Wagner, V., Brookes, S., McHugh, D., Pombo, J., Porreca, R. M., Dharmalingam, G., Vernia, S., Zuber, J., et al. (2021) · Genes & Development · doi:10.1101/gad.343269.120 · Cited by 30
“OIS occurs in premalignant lesions and limits tumorigenesis by arresting preneoplastic cells (Collado et al. 2005) and activating SASP-dependent Corresponding author: jesus.”
BackgroundSelf-citationInsights into 4E-BP1 and p53 mediated regulation of accelerated cell senescence
Chao, S. K., Horwitz, S. B., & McDaid, H. M. (2011) · Oncotarget · doi:10.18632/oncotarget.221 · Cited by 33
“Senescence is considered a potent tumor suppressive mechanism in vivo and thus, is regarded as a negative regulator of oncogenic transformation [5, 8-12].”
BackgroundInteraction of p53 with prolyl isomerases: Healthy and unhealthy relationships
Mantovani, F., Zannini, A., Rustighi, A., & Sal, G. D. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.01.013 · Cited by 37
“A number of studies have highlighted that incipient precancerous lesions are frequently prevented frommalignant progression by a permanent state of cell cycle arrest called senescence [83,84].”
BackgroundThe gut microbiota can orchestrate the signaling pathways in colorectal cancer
Bennedsen, A. L. B., Furbo, S., Bjarnsholt, T., Raskov, H., Gögenür, I., & Kvich, L. (2022) · Apmis · doi:10.1111/apm.13206 · Cited by 34
“common in pre-malignant tumors, affecting proliferation and restricting tumor progression [77].”
BackgroundNKX2.2 Suppresses Self-Renewal of Glioma-Initiating Cells
Muraguchi, T., Tanaka, S., Yamada, D., Tamase, A., Nakada, M., Nakamura, H., Hoshii, T., Ooshio, T., Tadokoro, Y., Naka, K., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2304 · Cited by 32
“S3C), or in SA-β-gal activity (data not shown) (20).”
BackgroundUne re-vue de la sénescence cellulaire: Ami ou ennemi de la promotion tumorale ?
Bischof, O., Dejean, A., & Pineau, P. (2009) · médecine/sciences · doi:10.1051/medsci/2009252153 · Cited by 32
The DNA repair function ofCUX1contributes to radioresistance
Ramdzan, Z. M., Ginjala, V., Pinder, J. B., Chung, D., Donovan, C. M., Kaur, S. J., Leduy, L., Dellaire, G., Ganesan, S., & Nepveu, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14875 · Cited by 35
de Galarreta, M. R., & Lujambio, A. (2017) · Nature Cell Biology · doi:10.1038/ncb3603 · Cited by 30
Rising from the ashes: cellular senescence in regeneration
Walters, H., & Yun, M. H. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.06.002 · Cited by 32
Dissecting the Senescence-like Program in Tumor Cells Activated by Ras Signaling
Bihani, T., Chicas, A., Lo, C. P.-K., & Lin, A. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608127200 · Cited by 32
Latella, L., Dall’Agnese, A., Sesillo, F. B., Nardoni, C., Cosentino, M., Lahm, A., Sacco, A., & Puri, P. (2017) · Genes & Development · doi:10.1101/gad.293266.116 · Cited by 32
“2B; Collado et al. 2005).”
Replication stress, a source of epigenetic aberrations in cancer?
Jasencakova, Z., & Groth, A. (2010) · BioEssays · doi:10.1002/bies.201000055 · Cited by 31
“Consistently, DDR is commonly activated in early pre-malignant lesions [58, 60], also showing presence of senescent cells [63, 64].”
BackgroundKamata, T., Jin, H., Giblett, S. M., PATEL, B., Patel, F., Foster, C., & Pritchard, C. A. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404838 · Cited by 34
“…knockin mice for oncogenic V600E BRAF and G12V/G12D KRAS have been previously generated by our group and others, and induction of oncogene expression in the lung in both models has been shown to induce premalignant lesions that up-regulate the expression of senescence markers (Collado et al ,…”
Valenzuela, C. A., Quintanilla, R., Olate‐Briones, A., Venturini, W., Mancilla, D., Cayo, Á., Moore‐Carrasco, R., & Brown, N. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215292 · Cited by 30
“Cellular senescence has been traditionally described as a non-proliferative process that limits aberrant proliferation of preneoplastic cells [10].”
BackgroundGupta, S., Pungsrinont, T., Ženata, O., Neubert, L., Vrzal, R., & Baniahmad, A. (2020) · Hormones and Cancer · doi:10.1007/s12672-020-00391-5 · Cited by 34
Prime, S. S., Cirillo, N., Cheong, S. C., Prime, M. S., & Parkinson, E. K. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.025 · Cited by 32
Revelations About Aging and Disease from Unconventional Vertebrate Model Organisms
Zhao, Y., Seluanov, A., & Gorbunova, V. A. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071719-021009 · Cited by 32
“Cellular senescence is an important anti-cancer mechanism preventing damaged or premalignant cells from proliferating (30; 192).”
BackgroundAnthracycline-induced cardiotoxicity and cell senescence: new therapeutic option?
Seara, F. D. A. C., Kasai-Brunswick, T. H., Nascimento, J. H. M., & de Carvalho, A. C. C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04605-7 · Cited by 30
“During anthracycline therapy, the DNA damage elicited by the ternary complex composed by anthracycline, DNA, and TopII and the oxidative stress can elicit cell senescence in neoplastic cells, resulting in cytostasis and preventing tumor growth [69].”
BackgroundTang, Y., Guo, C., Chen, C., & Zhang, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1100285 · Cited by 31
“Tumorsuppression characteristic of cell senescence has paved the way for a novel idea that enhances the senescence in tumor cells for cancer patients (Gertler et al., 2004; Collado et al., 2005; Calcinotto and Alimonti, 2017).”
BackgroundP21 Overexpression Promotes Cell Death and Induces Senescence in Human Glioblastoma
Mansour, M. A., Rahman, M., Ayad, A. A., Warrington, A. E., & Burns, T. C. (2023) · Cancers · doi:10.3390/cancers15041279 · Cited by 33
Kim, B. C., YOO, H. J., Lee, H., Kang, K. A., Jung, S. H., Lee, H. J., Lee, M., Park, S. W., JI, Y.-H., Lee, Y.-S., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3069 · Cited by 29
Senescence in pancreatic carcinogenesis: from signalling to chromatin remodelling and epigenetics
Singh, S. K., & Ellenrieder, V. (2013) · Gut · doi:10.1136/gutjnl-2012-302793 · Cited by 28
The significance of the senescence pathway in breast cancer progression
Pare, R. B., Yang, T., Shin, J., & Lee, C. S. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201081 · Cited by 34
Cellular Senescence as a Possible Mechanism for Halting Progression of Keloid Lesions
Varmeh, S., Egia, A., McGrouther, D. A., Tahan, S. R., Bayat, A., & Pandolfi, P. P. (2011) · Genes & Cancer · doi:10.1177/1947601912440877 · Cited by 31
Antagonistic TSC22D1 variants control BRAFE600‐induced senescence
Cornelia, H.-H., van Doorn, R., Vogel, C., Germann, M., Cecchini, M. G., Verdegaal, E. M. E., & Peeper, D. S. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.95 · Cited by 36
“…over the last 5 years several studies have demonstrated that OIS functions in vivo to suppress tumourigenesis (Braig et al, 2005; Chen et al, 2005; Collado et al, 2005; Michaloglou et al, 2005; Bartkova et al, 2006; Courtois-Cox et al, 2006; Gray-Schopfer et al, 2006; Dankort et al, 2007).”
BackgroundThe Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment
Lee, C. W., Baek, J., & Han, S. (2017) · Molecules · doi:10.3390/molecules22091411 · Cited by 31
“While OIS is considered to be a tumor suppression mechanism [91], pro-tumorigenic molecules are also secreted by senescent cells, manifesting the senescence-associated secretory phenotype (SASP) [92].”
Backgroundc-Myb and C/EBPβ regulate OPN and other senescence-associated secretory phenotype factors
Flanagan, K. C., Alspach, E., Pazolli, E., Parajuli, S. P., Ren, Q., Arthur, L., TAPIA-CONYER, R. C., & Stewart, S. A. (2017) · Oncotarget · doi:10.18632/oncotarget.22940 · Cited by 32
Oncogene‐induced senescence and melanoma: where do we stand?
Peeper, D. S. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00933.x · Cited by 31
Nagineni, C. N., Naz, S., Choudhuri, R., Chandramouli, G. V. R., Krishna, M. C., Brender, J., Cook, J. A., & Mitchell, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094835 · Cited by 29
“The presence of senescent cells and proliferating cancer cells within tumor tissues has been reported [6,7,9,29,30,38].”
BackgroundSenescent Cells in Cancer: Wanted or Unwanted Citizens
Niklander, S. E., Lambert, D., & Hunter, K. D. (2021) · Cells · doi:10.3390/cells10123315 · Cited by 28
Sun, R., Feng, J., & Wang, J. (2023) · Aging and Disease · doi:10.14336/ad.2023.0621 · Cited by 28
“…B1 [21], cellular senescent satellite-related expansion [22], differentiated embryo-chondrocyte expressed gene 1 and decoy receptor 2 expression [23], and the secretion of microRNAs, SASPs, or senescence information secretory group factors, such as cytokines, chemokines, and proteases [24][25].”
BackgroundMolecular pathology of non‐small cell carcinoma
Yatabe, Y. (2023) · Histopathology · doi:10.1111/his.15080 · Cited by 35
“Mutant KRAS expression simply induces epithelial hyperplasia, 116 – 118 and transformation to adenocarcinoma requires either a cooperating oncogene or tumour suppressor inactivation.”
BackgroundLee, J., Oh, E., Yoo, J. Y., Choi, K. S., Yoon, M. J., & Yun, C. (2015) · Oncotarget · doi:10.18632/oncotarget.3018 · Cited by 28
Oh, J. H., Gertych, A., & Tajbakhsh, J. (2013) · Oncotarget · doi:10.18632/oncotarget.942 · Cited by 30
“Investigations addressing the relationship between tumorigenesis and senescent cells, have led to earlier considerations hypothesizing that cellular senescence may act as a tumor suppressing mechanism [63–71].”
BackgroundEpigenetics and senescence: Learning from the INK4-ARF locus
Simboeck, E., Ribeiro, J. D., Teichmann, S., & Croce, L. D. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.084 · Cited by 34
Aging, cancer, and cancer vaccines
Mazzola, P., Radhi, S., Mirandola, L., Annoni, G., Jenkins, M., Cobos, E., & Chiriva‐Internati, M. (2012) · Immunity & Ageing · doi:10.1186/1742-4933-9-4 · Cited by 30
“Studies on advanced cancer disease have rarely demonstrated the presence of senescent cellular phenotypes [45,46].”
BackgroundScassa, M. É., Marazita, M. C., Ceruti, J. M., Carcagno, A. L., Sirkin, P. F., González‐Cid, M., Pignataro, O. P., & Cánepa, E. T. (2007) · DNA repair · doi:10.1016/j.dnarep.2006.12.003 · Cited by 29
RSK4 inhibition results in bypass of stress-induced and oncogene-induced senescence
López-Vicente, L., Pons, B., Coch, L., Teixidó, C., Hernández‐Losa, J., Armengol, G., & y Cajal, S. R. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr003 · Cited by 32
Induction of p38δ Expression Plays an Essential Role in Oncogenic ras-Induced Senescence
Kwong, J., Chen, M. S., Lv, D., Luo, N., Su, W., Xiang, R., & Sun, P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00784-13 · Cited by 29
“mutant human p53 (1-61) were prepared as described previously (27).”
BackgroundMethodSenescence and Cancer: Role of Nitric Oxide (NO) in SASP
Mabrouk, N., Ghione, S., Laurens, V., Plenchette, S., Bettaïeb, A., & Paul, C. (2020) · Cancers · doi:10.3390/cancers12051145 · Cited by 31
A Functional Screen for Regulators of CKDN2A Reveals MEOX2 as a Transcriptional Activator of INK4a
Irelan, J. T., del Arroyo, A. G., Gutierrez, A., Peters, G. G., Quon, K. C., Miraglia, L. J., & Chanda, S. K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005067 · Cited by 30
FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes
Hafner, C. M., di Martino, E., Pitt, E., Stempfl, T., Tomlinson, D. C., Hartmann, A., Landthaler, M., Knowles, M. A., & VOGT, T. M. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.021 · Cited by 28
“Oncogene-induced senescence is an important mechanism observed in benign tumors and inhibits the proliferation of cells carrying oncogenic mutations [37,38].”
BackgroundMolecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
Mittermeier, C., Konopa, A., & Muehlich, S. (2020) · Cells · doi:10.3390/cells9122540 · Cited by 31
RETRACTED: lncRNA TRMP-S directs dual mechanisms to regulate p27-mediated cellular senescence
Tian, S., Khan, M. R., Zhang, X. D., Li, J., Thorne, R. F., Wu, M., & Shao, F. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.04.004 · Cited by 30
RetractedThe Interplay Between miR-148a and DNMT1 Might be Exploited for Pancreatic Cancer Therapy
Zhan, Q., Fang, Y., Deng, X., Chen, H., Jin, J., Lu, X., Peng, C., Li, H., & Shen, B. (2015) · Cancer Investigation · doi:10.3109/07357907.2015.1025794 · Cited by 29
“Senescence is thought to be tumor suppressive because of its capability of compromising cell proliferation (17, 18).”
BackgroundLysyl oxidase activity regulates oncogenic stress response and tumorigenesis
Wiel, C., Augert, A., Vincent, D. F., Gitenay, D., Vindrieux, D., Calvé, B. L., Arfi, V., Lallet-Daher, H., Reynaud, C., Treilleux, I., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.382 · Cited by 30
“The following plasmids were used: pWZL-Neo-Myr-Flag-FAK (Addgene plasmid 20610, Cambridge, MA, USA),(48) pBabe-hygro-hTert (Addgene plasmid 1773),(49) pBAbe-puro-Raf:ER,(50) pNLP-Neo-Mek:ER.(3) For LOX and LOXL2 cloning, the C-terminally FLAG-tagged mouse LOX and LOXL2 cassettes were amplified by PCR with PFU (Agilent…”
Suppression of the p53-Dependent Replicative Senescence Response by Lysophosphatidic Acid Signaling
Kortlever, R. M., Brummelkamp, T. R., van Meeteren, L. A., Moolenaar, W. H., & Bernards, R. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0066 · Cited by 29
“Both in human tumors and in mouse models, it has recently been confirmed that in vivo senescence is also a bona fide tumor-suppressive mechanism and functions as a first barrier to oncogenic transformation (18-21).”
BackgroundFernández‐Ayala, D. J. M., Guerra, I., Jiménez-Gancedo, S., Cascajo, M. V., Gavilán, Á., DiMauro, S., Hirano, M., Briones, P., Artuch, R., de Cabo, R., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002524 · Cited by 27
Never-ageing cellular senescence
Öğrünç, M., & di Fagagna, F. D. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.04.003 · Cited by 38
IMR90 ER:RAS: A Cell Model of Oncogene-Induced Senescence
Innes, A. J., & Gil, J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8931-7_9 · Cited by 30
Self-citationZNF768 links oncogenic RAS to cellular senescence
Villot, R., Poirier, A., Bakan, I., Boulay, K., Fernández, E., Devillers, R., Braga, L. G., Tribouillard, L., Gagné, A., Duchesne, É., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24932-w · Cited by 32
Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care
Thompson, E. L., Pitcher, L. E., Niedernhofer, L. J., & Robbins, P. D. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000009668 · Cited by 29
The Myc/macrophage tango: Oncogene-induced senescence, Myc style
Lee, S., Schmitt, C. A., & Reimann, M. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.10.002 · Cited by 32
Huang, M. H., Lin, S. Z., Lin, P. C., Chiou, T., Harn, Y. W., Ho, L.-I., Chan, T.-M., Chou, C. W., Chuang, C. H., Su, H. L., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-1639-0 · Cited by 26
“Cellular senescence represents an irreversible form of cell-cycle arrest and can act as an important tumor-suppressive mechanism in various cancers [12, 13].”
BackgroundGagrica, S., Brookes, S., Anderton, E., Rowe, J., & Peters, G. G. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2552 · Cited by 28
“The down-regulation of INK4c occurs at the RNA level and has been previously documented in gene expression profiles of RAS-induced senescence (46-48), although these studies did not discuss the implications.”
Telomerase activation in a model of lung adenocarcinoma
Suau, F., Cottin, V., Archer, F., Croze, S., Chastang, J., Cordier, G., Thivolet-Béjui, F., Mornex, J., & Leroux, C. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00125105 · Cited by 26
Werner syndrome through the lens of tissue and tumour genomics
Tokita, M., Kennedy, S. R., Risques, R. A., Chun, S. G., Pritchard, C. C., Oshima, J., Liu, Y., BRYANT-GREENWOOD, P. K., Welcsh, P. L., & Monnat, R. J. (2016) · Scientific Reports · doi:10.1038/srep32038 · Cited by 28
CUT Domain Proteins in DNA Repair and Cancer
Ramdzan, Z. M., Vickridge, E., Faraco, C. C. F., & Nepveu, A. (2021) · Cancers · doi:10.3390/cancers13122953 · Cited by 26
Kim, M. O., Kim, S., Oi, N., Lee, M. H., Yu, D. H., Kim, D. J., Cho, E. J., Bode, A. M., Cho, Y., Bowden, T. G., et al. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00891.x · Cited by 26
“Senescence is a growth-arrested state in cultured cells where metabolically active cells undergo stable cell cycle arrest at the G1 phase (Collado et al., 2005; Lowe et al., 2004; Serrano et al., 1997; Sharpless and Depinho, 2005).”
Thyroid hormone induces cellular senescence in prostate cancer cells through induction of DEC1
Kotolloshi, R., Mirzakhani, K., Ahlburg, J., Kraft, F., Pungsrinont, T., & Baniahmad, A. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105689 · Cited by 39
Mesenchymal Stem Cell Senescence and Osteogenesis
Tjempakasari, A., Suroto, H., & Santoso, D. (2021) · Medicina · doi:10.3390/medicina58010061 · Cited by 29
Toll-like receptor 2 orchestrates a tumor suppressor response in non-small cell lung cancer
Millar, F. R., Pennycuick, A., Muir, M., Quintanilla, A., Hari, P., Freyer, E., Gautier, P. E., Meynert, A. M., Grimes, G. R., Salomo-Coll, C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111596 · Cited by 32
“Markers of OIS are widespread in preinvasive lung tumors in mice but are lost during progression to invasive malignancy (Collado et al., 2005).”
N7-methylguanosine methylation of tRNAs regulates survival to stress in cancer
García-Vílchez, R., Añazco-Guenkova, A. M., López, J., Dietmann, S., Tomé, M., Jimeno, S., Azkargorta, M., Elortza, F., Bárcena, L., González-Lopez, M., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02825-0 · Cited by 27
“Excessive DNA damage can induce both cell death or cell cycle arrest through senescence [64], which has both tumour-suppressive and drug-tolerant persistence characteristics [65, 66].”
BackgroundSenescence and senolysis in cancer: The latest findings
Imawari, Y., & Nakanishi, M. (2024) · Cancer Science · doi:10.1111/cas.16184 · Cited by 26
“60 Nevertheless, once the cells become senescent cells, proinflammatory SASPs cause chronic inflammation in the surrounding tissues and promote cancer.”
BackgroundNovel ARF/p53-independent senescence pathways in cancer repression
Chan, C., Gao, Y., Moten, A., & Lin, H. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0766-y · Cited by 29
“One study showed that there was no senescence in lung lesions of KRas knock-in mice, but another study revealed that senescence occurs in lung adenomas of KRas knock-in mice [65, 66].”
BackgroundYB 1 binds to and represses the p16 tumor suppressor gene
Kotake, Y., Ozawa, Y., Harada, M., Kitagawa, K., Niida, H., Morita, Y., Tanaka, K., Suda, T., & Kitagawa, M. (2013) · Genes to Cells · doi:10.1111/gtc.12093 · Cited by 29
Do we age because we have mitochondria?
Bereiter‐Hahn, J. (2013) · PROTOPLASMA · doi:10.1007/s00709-013-0515-x · Cited by 28
Epimorphic regeneration in mice is p53-independent
Arthur, L. M., Demarest, R. M., Clark, L. D., Gourevitch, D., Bedelbaeva, K., Anderson, R., Snyder, A. R., Capobianco, A. J., Lieberman, P. M., Feigenbaum, L., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.18.13119 · Cited by 26
Oncogene-Induced Senescence and its Role in Tumor Suppression
Reddy, J. P., & Li, Y. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9221-5 · Cited by 30
“To address this, Serrano and colleagues [17] employed genetic screening approaches to find better and more physiologically relevant markers that correctly identify senescent cells.”
BackgroundInfluentialESE‐3, an Ets family transcription factor, is up‐regulated in cellular senescence
Fujikawa, M., Katagiri, T., Tugores, A., Nakamura, Y., & Ishikawa, F. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00543.x · Cited by 24
The switch from pRb/p105 to Rb2/p130 in DNA damage and cellular senescence
Helmbold, H., Galderisi, U., & Bohn, W. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22786 · Cited by 25
“InG1,ORC serves as a platformwhereCdc6 and Cdt1 first bind and facilitate the loading of the replicative DNA helicase (Mcm 2-7) to generate the pre-replication complex (pre-RC) (Cook et al., 2002; Xouri et al., 2007).”
BackgroundPeng, D., Song, H. K., & Liu, L. (2015) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-015-1457-7 · Cited by 26
Expression of tumor-related Rac1b antagonizes B-Raf-induced senescence in colorectal cells
Henriques, A. F. A., Barros, P., Moyer, M. P., Matos, P., & Jordan, P. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.08.027 · Cited by 26
“B-Raf-induced OIS has also been determined in situ in benign tumors of melanocytes called nevi [20], in lung cancer mouse models [21] and in the serrated route to colorectal cancer [22].”
BackgroundIng1 Mediates p53 Accumulation and Chromatin Modification in Response to Oncogenic Stress
Abad, M., Menéndez, C., Füchtbauer, A. C., Serrano, M., Füchtbauer, E., & Palmero, I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701639200 · Cited by 31
Self-citationThe Par-4/PTEN connection in tumor suppression
Díaz-Meco, M. T., & Abu‐Baker, S. (2009) · Cell Cycle · doi:10.4161/cc.8.16.9384 · Cited by 25
Shyamala, G., Chou, Y.-C., Cardiff, R. D., & Vargis, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0321 · Cited by 25
Accumulation of annexin A5 at the nuclear envelope is a biomarker of cellular aging
Klement, K., Melle, C., Murzik, U., Diekmann, S., Norgauer, J., & Hemmerich, P. H. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.06.003 · Cited by 34
Molecular biology of pancreatic cancer--new aspects and targets.
Schneider, G., Hamacher, R., Eser, S., Frieß, H., Schmid, R. M., & Saur, D. (2008) · PubMed · Cited by 36
The activation of cGAS-STING pathway offers novel therapeutic opportunities in cancers
Wang, Y., Zhu, Y., Cao, Y., Li, Y., Zhang, Z., Fleishman, J. S., Cheng, S., Chen, J., & Ding, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1579832 · Cited by 43
“From such, it may be currently used as a common mechanism underlying current anticancer therapies (65, 71 – 73).”
Guégan, J., Ezan, F., Gailhouste, L., Langouët, S., & Baffet, G. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24521 · Cited by 26
“…from the expression of active mutants of Ras, Raf, or MEK1/2, induced the in vitro transformation of fibroblasts or epithelial cells (Brunet et al., 1994; Cowley et al., 1994; Voisin et al., 2008) as well as the hypertrophy of different tissues in vivo (Bueno et al., 2000; Scholl et al., 2004).”
BackgroundGhosh, A., Lai, C. S. L., McDonald, S., Suraweera, N., Sengupta, N., PROPPER, D. J., Dorudi, S., & Silver, A. R. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.09.001 · Cited by 27
Evidence of cellular senescence during the development of estrogen-induced pituitary tumors
Sabatino, M. E., Petiti, J. P., Sosa, L. D. V., Pérez, P. A., Gutiérrez, S., Leimgruber, C., Latini, A., Torres, A. I., & Paul, A. L. D. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0333 · Cited by 28
“Cellular senescence can be interpreted as a spontaneous initial barrier in tumorigenesis, because senescent cells are abundant within pre-malignant lesions, whereas they rarely appear in malignant tumors (Collado et al. 2005).”
BackgroundTCF7L1 promotes skin tumorigenesis independently of β-catenin through induction of LCN2
Ku, A. T., Shaver, T. M., Rao, A. S., Howard, J. M., Rodriguez, C. N., Miao, Q., Garcia, G. E., Le, D. N., Yang, D., Borowiak, M., et al. (2017) · eLife · doi:10.7554/elife.23242 · Cited by 27
“In tissues where expression of oncogenic HRAS promotes tumor formation, senescence markers are found abundantly in premalignant lesions but are absent in carcinomas (Collado et al., 2005).”
BackgroundExploiting cellular senescence to treat cancer and circumvent drug resistance
Yan, Q., & Wajapeyee, N. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.3.11166 · Cited by 24
Harajly, M., Zalzali, H., Nawaz, Z., Ghayad, S. E., Ghamloush, F., Basma, H., Zainedin, S., Rabeh, W., Jabbour, M. N., Tawil, A. N., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00747-15 · Cited by 24
“2C, columns 4 and 5, compare top and middle rows), additional markers of senescence (2, 21, 22).”
BackgroundWang, Y., Xu, Q., Sack, L. M., Kang, C., & Elledge, S. J. (2016) · Genes & Development · doi:10.1101/gad.271445.115 · Cited by 24
“Many senescence regulators, such as p16 and p53, are also known to prevent tumorigenesis (Chen et al. 2005; Collado 2005; Michaloglou et al. 2005).”
BackgroundVaishnavi, A., Scherzer, M. T., Kinsey, C. G., Parkman, G. L., Truong, A., Ghazi, P., Schuman, S., Battistone, B., Garrido-Laguna, I., & McMahon, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107994 · Cited by 23
“Indeed, it has previously been shown that activation of RAF>MEK>ERK signaling at different levels can drive strikingly different biological outcomes, some of which are mediated by engagement of various tumor suppressors and/or regulators of the cell cycle or apoptosis (Collado et al., 2005; Marshall, 1995; Murphy et a…”
BackgroundPare, R., Soon, P. S., Shah, A., & Lee, C. S. (2019) · PLOS ONE · doi:10.1371/journal.pone.0214604 · Cited by 23
Suppression of human tumor cell proliferation by Smurf2‐induced senescence
Zhang, H., Teng, Y., Kong, Y., Kowalski, P. E., & Cohen, S. N. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21337 · Cited by 23
“4A, lanes 11 and 16)], TE85, 143B, RD, T98G, MDA-MB-231, MDA-MB-435, J82, and T24 [containing homo/hemizygous mutant p53 but normal pRb (Romano et al., 1989; Felix et al., 1992; Cooper et al., 1994; Van Meir et al., 1994; O’Connor et al., 1997; also see Fig.”
BackgroundOta, K., Dohi, Y., Brydun, A., Nakanome, A., Ito, S., & Igarashi, K. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3574 · Cited by 26
“The fact that it can be seen in premalignant tumors (13) shows that it is one of the critical inhibitors of tumor progression.”
Maintenance of Genomic Stability in Mouse Embryonic Stem Cells: Relevance in Aging and Disease
Giachino, C., Orlando, L., & Turinetto, V. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022617 · Cited by 27
Role of cellular senescence in hepatic wound healing and carcinogenesis
Ramakrishna, G., Anwar, T., Angara, R. K., Chatterjee, N., Kiran, S., & Singh, S. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2012.08.002 · Cited by 23
Shining the Light on Senescence Associated LncRNAs
Ghanam, A. R., Xu, Q., Ke, S., Azhar, M., Cheng, Q., & Song, X. (2017) · Aging and Disease · doi:10.14336/ad.2016.0810 · Cited by 26
“Several proteins that accumulate at SAHF are valuable senescence markers such as HMGA, HIRA, HP1 and H3K9me3 in the in vitro senescence [115] and in vivo senescence [116].”
Chen, J., Zhang, W., Chen, K.-H., Lin, L.-R., Dai, H., Li, K., Zhang, J., Zheng, L., Fu, B.-Q., & He, Y. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00689.2016 · Cited by 24
“DcR2-positive tumor cells have been used to assess the degree of differentiation, predict sensitivity to antitumor drugs, and estimate prognosis (3, 13, 32).”
BackgroundNeault, M., Couteau, F., Bonneau, É., Guire, V. D., & Mallette, F. A. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.04.001 · Cited by 23
Hoare, M., & Narita, M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-89512-3_15 · Cited by 24
The impact of age on oncogenic potential: tumor-initiating cells and the brain microenvironment
Stoll, E. A., Horner, P. J., & Rostomily, R. (2013) · Aging Cell · doi:10.1111/acel.12104 · Cited by 26
“The idea that senescence might actually ‘precondition’ cells for oncogenic transformation is gaining traction recently: markers of senescence are evident in premalignant adenomas, but not in advanced adenocarcinomas in a mouse model of RAS-induced tumorigenesis (Collado et al., 2005).”
BackgroundSenescence as a modulator of oral squamous cell carcinoma development
Parkinson, E. K. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2009.09.009 · Cited by 26
Autophagy and senescence, converging roles in pathophysiology as seen through mouse models
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2021.02.001 · Cited by 20
Metadata
- Authors
- Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., Beach, D., & Serrano, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Imperial College London (GB)
- Consejo Superior de Investigaciones Científicas (ES)
- Universidad Complutense de Madrid (ES)
- Corresponding author
- Serrano, Manuel
- ORCID
- Venue
- Nature
- Published
- 2005-08-04
- Volume
- 436
- Issue
- 7051
- Pages
- 642-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2067117191
- Cited by
- 1,482
- References
- 7
- Citations by year
- 2026: 31 · 2025: 40 · 2024: 59 · 2023: 58 · 2022: 57 · 2021: 74 · 2020: 87 · 2019: 55 · 2018: 53 · 2017: 68 · 2016: 67 · 2015: 73 · 2014: 76 · 2013: 81 · 2012: 81
- FWCI
- 46.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, oncogene-induced senescence, oncogenic Ras, lymphoma, SUV39H1, histone methyltransferase, epigenetic regulation, melanoma, p53, PTEN mutation, prostate cancer, tumor suppression, cancer diagnosis and prognosis
- MeSH terms
- Adenocarcinoma, Alleles, Animals, beta-Galactosidase, Cell Transformation, Neoplastic, Disease Models, Animal, Heterochromatin, Lung Neoplasms, Mice, Transgenic, Precancerous Conditions, Genes, ras, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Cellular Senescence, Disease Progression, Cyclin-Dependent Kinase Inhibitor p16, Oligonucleotide Array Sequence Analysis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.